gsk glp 1 agonist List of GLP-1 Receptor Agonists for Diabetes & Weight Loss Emerging Frontiers in GLP-1 Therapeutics:

By sticking to a "clean label" philosophy, we reduce the guesswork for our community

For textural issues like indented scars, options range from chemical peels for mild cases, to excision, filler injections, or laser therapy for more pronounced scars

PMID: 28535802

A provider evaluation is needed before considering any peptide therapy

Removed from 503B Compounding (2024) CJC-1295 (with or without DAC) Growth hormone release Ipamorelin Growth hormone release Thymosin Alpha-1 Immune support AOD-9604 Fat loss Note: BPC-157 and TB-500 were removed from 503B outsourcing facility compounding in 2024 but remain available through 503A compounding pharmacies via patient-specific prescriptions